These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
414 related items for PubMed ID: 19293181
21. In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow. van Gent R, Kater AP, Otto SA, Jaspers A, Borghans JA, Vrisekoop N, Ackermans MA, Ruiter AF, Wittebol S, Eldering E, van Oers MH, Tesselaar K, Kersten MJ, Miedema F. Cancer Res; 2008 Dec 15; 68(24):10137-44. PubMed ID: 19074880 [Abstract] [Full Text] [Related]
22. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1). Wang HS, Hung Y, Su CH, Peng ST, Guo YJ, Lai MC, Liu CY, Hsu JW. Exp Cell Res; 2005 Mar 10; 304(1):116-26. PubMed ID: 15707579 [Abstract] [Full Text] [Related]
23. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases]. Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B. Acta Med Croatica; 2008 Oct 10; 62(4):351-64. PubMed ID: 19205412 [Abstract] [Full Text] [Related]
24. Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model. Aydin S, Grabellus F, Eisele L, Möllmann M, Hanoun M, Ebeling P, Moritz T, Carpinteiro A, Nückel H, Sak A, Göthert JR, Dührsen U, Dürig J. Eur J Haematol; 2011 Jul 10; 87(1):10-9. PubMed ID: 21692849 [Abstract] [Full Text] [Related]
26. Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells. Vuckovic S, Abdul Wahid FS, Rice A, Kato M, Khalil D, Rodwell R, Hart DN. Exp Hematol; 2008 Nov 10; 36(11):1496-506. PubMed ID: 18715688 [Abstract] [Full Text] [Related]
27. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia. Montresor A, Toffali L, Mirenda M, Rigo A, Vinante F, Laudanna C. Oncotarget; 2015 Oct 27; 6(33):34245-57. PubMed ID: 26413812 [Abstract] [Full Text] [Related]
28. Integrin-mediated long-term B cell retention in the splenic marginal zone. Lu TT, Cyster JG. Science; 2002 Jul 19; 297(5580):409-12. PubMed ID: 12130787 [Abstract] [Full Text] [Related]
29. Two maturation-associated mouse erythrocyte receptors of human B cells. I. Identification of four human B-cell subsets. Forbes IJ, Zalewski PD, Valente L, Gee D. Clin Exp Immunol; 1982 Feb 19; 47(2):396-404. PubMed ID: 6978783 [Abstract] [Full Text] [Related]
30. A high endothelial cell-derived chemokine induces rapid, efficient, and subset-selective arrest of rolling T lymphocytes on a reconstituted endothelial substrate. Tangemann K, Gunn MD, Giblin P, Rosen SD. J Immunol; 1998 Dec 01; 161(11):6330-7. PubMed ID: 9834123 [Abstract] [Full Text] [Related]
31. Bone marrow cells as cytostatic effectors responsible for suppressing leukemia growth in vitro. Seledtsov VI, Avdeev IV, Seledtsova GV, Samarin DM, Prokopenko IV, Kozlov VA. Biomed Pharmacother; 1995 Dec 01; 49(6):293-9. PubMed ID: 7579011 [Abstract] [Full Text] [Related]
32. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Yoneyama H, Matsuno K, Zhang Y, Nishiwaki T, Kitabatake M, Ueha S, Narumi S, Morikawa S, Ezaki T, Lu B, Gerard C, Ishikawa S, Matsushima K. Int Immunol; 2004 Jul 01; 16(7):915-28. PubMed ID: 15159375 [Abstract] [Full Text] [Related]
34. Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. Spessotto P, Zucchetto A, Degan M, Wasserman B, Danussi C, Bomben R, Perris R, Canzonieri V, Radillo O, Colombatti A, Gattei V. Matrix Biol; 2007 Jul 01; 26(6):473-84. PubMed ID: 17482449 [Abstract] [Full Text] [Related]
35. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Shanafelt TD, Kay NE. Semin Oncol; 2006 Apr 01; 33(2):174-85. PubMed ID: 16616064 [Abstract] [Full Text] [Related]
36. Comparison of immunophenotypes of small B-cell neoplasms in primary lymph node and concurrent blood or marrow samples. Xu Y, McKenna RW, Asplund SL, Kroft SH. Am J Clin Pathol; 2002 Nov 01; 118(5):758-64. PubMed ID: 12428797 [Abstract] [Full Text] [Related]
37. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Palumbo GA, Parrinello N, Fargione G, Cardillo K, Chiarenza A, Berretta S, Conticello C, Villari L, Di Raimondo F. Leuk Res; 2009 Sep 01; 33(9):1212-6. PubMed ID: 19230971 [Abstract] [Full Text] [Related]
38. Cyclical expression of L-selectin (CD62L) by recirculating T cells. Klinger A, Gebert A, Bieber K, Kalies K, Ager A, Bell EB, Westermann J. Int Immunol; 2009 Apr 01; 21(4):443-55. PubMed ID: 19240088 [Abstract] [Full Text] [Related]
39. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. Di Ianni M, Moretti L, Terenzi A, Bazzucchi F, Del Papa B, Bazzucchi M, Ciurnelli R, Lucchesi A, Sportoletti P, Rosati E, Marconi PF, Falzetti F, Tabilio A. Cytotherapy; 2009 Apr 01; 11(1):86-96. PubMed ID: 19153855 [Abstract] [Full Text] [Related]